Assess whether product recall exposure is priced or excluded (b2ba5c)

SITUATION A fleet with a new ELD vendor and rising frequency cannot treat a product that just got an FDA warning letter as incidental context on D&O claims-made notice and prior-acts history. Commercial property underwriter must close product recall exposure is from that extract under Insurance Underwriting / Treaty and Excess.

DECISION Commercial property underwriter in a fleet with a new ELD vendor and rising frequency must choose Product recall exposure is priced / Excluded using D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter.

HYPOTHESES TO TEST 1. Commercial property underwriter can defend Product recall exposure is priced from D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter in a Insurance Underwriting challenge. 2. Commercial property underwriter cannot defend Product recall exposure is priced from D&O claims-made notice and prior-acts history; Excluded is what the extract actually supports after a product that just got an FDA warning letter. 3. A product that just got an FDA warning letter never reached the population in D&O claims-made notice and prior-acts history — reopen intake, do not close product recall exposure is. 4. Two facts in D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter conflict for commercial property underwriter; hold this Treaty and Excess file.

ANALYSIS REQUIRED 1. Flag any accumulation fact D&O claims-made notice and prior-acts history does not price. 2. Compare treaty versus facultative treatment for the risk product recall exposure is names. 3. Check the submission completeness against a product that just got an FDA warning letter. 4. For this Insurance Underwriting Treaty and Excess file, read D&O claims-made notice and prior-acts history against a product that just got an FDA warning letter and write the one fact that would move product recall exposure is for commercial property underwriter.

RECOMMENDATION Choose Product recall exposure is priced / Excluded on this Insurance Underwriting / Treaty and Excess packet (D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter). The follow-on Treaty and Excess action is what commercial property underwriter does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line Insurance Underwriting option on product recall exposure is, then the evidence in D&O claims-made notice and prior-acts history, then the action for commercial property underwriter - Hypothesis scorecard against D&O claims-made notice and prior-acts history: supported / rejected / untestable - Treaty and Excess finding in D&O claims-made notice and prior-acts history that a second reviewer can re-perform - Missing page in D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter, if any